Table 2.
T0 | T1 | T2 | ||||
---|---|---|---|---|---|---|
Baseline | End of Treatment | 3 Months Post-Treatment | ||||
n (%) | n (%) | p and r Value | n (%) | p and r Value | ||
No Disability | Control | 1 (3.8%) | 6 (23.1%) |
p < 0.122 r = 0.23 |
9 (34.6%) |
p < 0.063 r = 0.24 |
IST | 3 (11.5%) | 7 (26.9%) | 7 (26.9%) | |||
UCTM | 2 (7.7%) | 12 (46.2%) | 15 (57.7%) | |||
Mild Disability | Control | 17 (65.4%) | 14 (53.8%) | 13 (50%) | ||
IST | 10 (28.5%) | 15 (57.7%) | 17 (65.4%) | |||
UCTM | 14 (53.8%) | 13 (50%) | 11 (42.3%) | |||
Moderate Disability | Control | 7 (26.9%) | 5 (19.2%) | 4 (15.4%) | ||
IST | 12 (46.2%) | 4 (15.4%) | 2 (7.7%) | |||
UCTM | 8 (30.8%) | 1 (3.8%) | 0 (0%) | |||
Severe Disability | Control | 1 (3.8%) | 1 (3.8%) | 0 (0%) | ||
IST | 1 (3.8%) | 0 (0%) | 0 (0%) | |||
UCTM | 1 (3.8%) | 0 (0%) | 0 (0%) | |||
Complete Disability | Control | 0 (0%) | 0 (0%) | 0 (0%) | ||
IST | 0 (0%) | 0 (0%) | 0 (0%) | |||
UCTM | 1 (3.8%) | 0 (0%) | 0 (0%) |
Abbreviations: IST, inhibitory suboccipital technique; UCTM, upper cervical translatoric mobilization; r; Cramer’s V.